Drugs of Limited Clinical Value Policy

The purpose of this policy is to support the decision making process associated with the allocation of resources for prescribing of drugs and appliances, establishing a framework within which the CCG can demonstrate that their decision making processes are fair, equitable and legally sound.

This policy is designed to help the CCG meet their obligation in providing equitable access to healthcare.

The NHS Constitution identifies two key patient rights with regard to medicines:

“You have the right to drugs and treatments that have been recommended by NICE for use in the NHS, if your doctor says they are clinically appropriate for you.”


 “You have the right to expect local decisions on funding of other drugs and treatments to be made rationally following a proper consideration of the evidence. If the local NHS decides not to fund a drug or treatment you and your doctor feel would be right for you, they will explain that decision to you.”

The courts have established that a CCG is not under an absolute obligation to provide every treatment that a patient requests. A CCG can develop a policy which prioritises treatment to take account of the resources available to it and the competing demands on those resources. Prescribing of medicines in the NHS is on the basis of clinical need. The Isle of Wight CCG supports cost-effective prescribing to ensure fair use of resources.

Omega 3 leaflet

Omega 3 supplements are no longer available on prescription. Please see the patient information letter.

AMD vitamins

Vitamin supplements are no longer available on prescription for patients with Age Related Macular Degeneration.

Liothyronine Guidance

Liothyronine should only be prescribed in certain circumstances, these are explained in our guidance document.